AbbVie
ABBV
#25
Rank
A$594.01 B
Marketcap
$336.48
Share price
-0.24%
Change (1 day)
23.99%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of March 2025 (TTM): 6.63

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 111. At the end of 2024 the company had a P/S ratio of 5.58.

P/S ratio history for AbbVie from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.5810.86%
20235.042.32%
20224.9215.58%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.41-63.59%๐Ÿ‡บ๐Ÿ‡ธ USA
2.53-61.80%๐Ÿ‡บ๐Ÿ‡ธ USA
16.0 141.13%๐Ÿ‡บ๐Ÿ‡ธ USA
5.02-24.20%๐Ÿ‡บ๐Ÿ‡ธ USA
4.99-24.75%๐Ÿ‡บ๐Ÿ‡ธ USA
2.12-68.06%๐Ÿ‡บ๐Ÿ‡ธ USA
1.99-69.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.39-33.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.61-30.41%๐Ÿ‡บ๐Ÿ‡ธ USA